about
Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.Bioimpedance spectroscopy for the detection of fluid overload in Chinese peritoneal dialysis patients.Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus.Urinary expression of kidney injury markers in renal transplant recipients.Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases.Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis.Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysisCirculating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patientsThe Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia.Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases.Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.Campylobacter peritonitis complicating peritoneal dialysis: a review of 12 consecutive cases.Predicting 12-month mortality for peritoneal dialysis patients using the "surprise" questionLipoprotein metabolism and lipid management in chronic kidney disease.Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases.A story half untold: adiposity, adipokines and outcomes in dialysis population.Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.Influence of climate on the incidence of thiazide-induced hyponatraemia.Dialysate bacterial endotoxin as a prognostic indicator of peritoneal dialysis related peritonitis.Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.Arterial pulse wave velocity and peritoneal transport characteristics independently predict hospitalization in Chinese peritoneal dialysis patients.Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.Recurrent and relapsing peritonitis: causative organisms and response to treatment.Association of interleukin-18 promoter polymorphism and atherosclerotic diseases in Chinese patients with diabetic nephropathy.The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species.Spurious hypernatraemia.Longitudinal changes of cardiothoracic ratio and vascular pedicle width as predictors of volume status during one year in Chinese peritoneal dialysis patients.Adherence to peritoneal dialysis training schedule.Asymptomatic isolated microscopic haematuria: long-term follow-up.Relationship between myeloid-related protein 8/14 and survival of Chinese peritoneal dialysis patients.Treatment of early immunoglobulin A nephropathy by angiotensin-converting enzyme inhibitor.Treatment of Enterococcal Peritonitis in Peritoneal Dialysis Patients by Oral Amoxicillin or Intra-Peritoneal Vancomcyin: a Retrospective Study.Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.Urinary mRNA in systemic lupus erythematosus.Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.The relationship between bone morphogenic protein-7 and peritoneal transport characteristics.Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.
P50
Q33770004-61C474E9-2ABB-4D0A-BCBD-9D637A205432Q33837680-63CD05DD-86CC-4700-BC65-7F3A80E4D512Q34144124-72C083A3-B530-4192-B283-DB33AE3BE891Q34362781-0DE56BF1-7369-4A03-9115-6C3D49B3BEF7Q34658582-2D2A6A6C-0C62-4E7D-88CF-56758F452DBBQ34751892-2A493112-124F-4B29-A6F5-750246D562AEQ34762155-1AC34E31-C5E6-4F3C-B9E6-D4E824D3A7C9Q35524742-C0B8805F-5B9B-49EC-A6D0-AD599E764EC2Q35641502-92B2098F-621E-484A-B3A7-FE1558095C7FQ35824659-CC73CB4E-6AA4-469C-A230-6742BD8E9316Q36253639-2BC3C865-6638-4C4B-902D-67867BB2CDE7Q36391814-BC0C3F21-25E7-486D-A55C-C075AA204513Q36667013-E5EDAD3B-3E1C-43DF-9B35-563EB738B1F3Q36686011-033BBDC8-7DF0-4EBD-8859-5A9885CDCFFEQ36686544-9AA0AD85-3E14-4830-8F37-379C9C771E26Q36759896-65D64403-3121-4058-8ADF-464C82C3693DQ36910551-F21AF0AA-5767-49CD-A6D6-23480CDEDF37Q36996664-9DA9FE16-88E1-4D6D-9A1F-769883CA1B09Q37510473-BBC41909-C0F8-474F-AA06-73FB65CEC3FCQ38466835-13386027-6B1F-47A4-8103-BECE0C4E1F7CQ40442459-6F76693F-A012-40EA-9BED-7EF3C6F858E0Q40799557-BA6FE6FA-03C9-47B6-B70B-62FFBB901AC6Q43199806-044C9C62-560C-40F1-979E-53A9C596A4D2Q43602339-A7684721-F670-44B3-BA44-E3340787CD8FQ44047843-90AB385C-AD6A-4EDD-8C3A-CF5DD95C85EAQ44109725-E9EB5394-2B85-44F0-BCCB-164262CB499CQ44505770-1093E48C-2D97-4277-A3D5-C00832114CF4Q44670055-D819063E-605E-44E1-A2EA-835B857E375EQ44826109-23B26472-FAB2-4170-8264-50949566B328Q44902223-DE39D3C2-CDD2-4E51-918D-5D1E0A604730Q45117037-5C8DEE76-62F7-478A-9A77-D7FE6E43BDC9Q45369368-DFB9E602-C3FB-47A6-A586-5EC5375A083FQ46036817-F200BC50-E5A1-460E-8405-3313A658D990Q46274032-13D1BFAD-C0C9-4E74-ABF2-CEE28B0B2730Q46407226-21FECB01-4D0A-4C0C-8A76-266DC66F3F35Q46604873-EC23B541-7854-4E4B-9F9E-86BAE45096F9Q46640606-88B7A288-4973-45C2-9F90-B6453A2ECD67Q46654014-7D4D7DD1-CC68-4F5F-AF19-38575EDD55AEQ46734065-B02D5144-1355-4843-96CC-57485CD626E6Q47274203-35BF7213-721F-41E7-95DB-94F107067AF6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bonnie Ch Kwan
@ast
Bonnie Ch Kwan
@en
Bonnie Ch Kwan
@es
Bonnie Ch Kwan
@nl
Bonnie Ch Kwan
@sl
type
label
Bonnie Ch Kwan
@ast
Bonnie Ch Kwan
@en
Bonnie Ch Kwan
@es
Bonnie Ch Kwan
@nl
Bonnie Ch Kwan
@sl
prefLabel
Bonnie Ch Kwan
@ast
Bonnie Ch Kwan
@en
Bonnie Ch Kwan
@es
Bonnie Ch Kwan
@nl
Bonnie Ch Kwan
@sl
P1053
N-3463-2015
N-4082-2015
P106
P31
P3829
P496
0000-0001-6742-8480